跳至主要内容
临床试验/IRCT20220406054431N1
IRCT20220406054431N1招募中2 期

Determining the efficacy of quadruple standard regimen combined with simvastatin, probiotic, and NAC as adjuvant therapy for H. Pylori eradication and comparing to standard treatment

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 168 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
168

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • People over the age of 18 and under 65
  • With positive stool antigen test or endoscopy for Helicobacter pylori

排除标准

  • History of heart, kidney and liver failure
  • Developing an active cancer
  • Drug and alcohol addiction
  • Recent history of gastrointestinal bleeding
  • Get previous treatment

研究者

相似试验